Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China
· Delayed Price · Currency is CNY 6.13
+0.20 (3.37%)
Apr 29, 2026, 3:04 PM CST
SHE:300639 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 3,847 | 3,377 | 3,772 | 5,990 | 7,361 | 8,595 | Upgrade
|
| Market Cap Growth | 8.20% | -10.48% | -37.03% | -18.63% | -14.35% | -2.84% | Upgrade
|
| Enterprise Value | 2,812 | 2,432 | 3,054 | 5,316 | 6,815 | 7,868 | Upgrade
|
| Last Close Price | 6.13 | 5.38 | 5.93 | 9.24 | 10.84 | 12.52 | Upgrade
|
| PE Ratio | - | - | - | 42.64 | 4.26 | 10.09 | Upgrade
|
| Forward PE | - | 18.89 | 24.20 | 23.95 | 4.88 | 12.96 | Upgrade
|
| PS Ratio | 5.75 | 5.04 | 4.63 | 5.42 | 1.32 | 3.22 | Upgrade
|
| PB Ratio | 1.05 | 0.92 | 0.93 | 1.18 | 1.41 | 2.47 | Upgrade
|
| P/TBV Ratio | 1.10 | 0.97 | 0.98 | 1.30 | 1.56 | 2.78 | Upgrade
|
| P/FCF Ratio | 15.44 | 13.55 | - | - | 12.81 | - | Upgrade
|
| P/OCF Ratio | 11.26 | 9.88 | 47.88 | 18.74 | 5.62 | 13.61 | Upgrade
|
| EV/Sales Ratio | 4.20 | 3.63 | 3.75 | 4.81 | 1.22 | 2.94 | Upgrade
|
| EV/EBITDA Ratio | 123.28 | 140.20 | - | 33.24 | 2.63 | 6.98 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 2.81 | 7.52 | Upgrade
|
| EV/FCF Ratio | 11.28 | 9.76 | - | - | 11.86 | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 3.93 | 3.93 | - | 0.33 | 0.05 | 0.16 | Upgrade
|
| Debt / FCF Ratio | 0.36 | 0.36 | - | - | 0.24 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.26 | -0.26 | -0.22 | -0.20 | -0.24 | -0.29 | Upgrade
|
| Net Debt / EBITDA Ratio | -54.72 | -54.72 | 1.34 | -6.35 | -0.49 | -0.90 | Upgrade
|
| Net Debt / FCF Ratio | -3.81 | -3.81 | 12.59 | 15.45 | -2.21 | 104.21 | Upgrade
|
| Asset Turnover | 0.15 | 0.15 | 0.16 | 0.18 | 1.02 | 0.75 | Upgrade
|
| Inventory Turnover | 5.73 | 5.73 | 5.33 | 4.05 | 13.59 | 7.11 | Upgrade
|
| Quick Ratio | 4.98 | 4.98 | 4.70 | 5.86 | 3.05 | 3.44 | Upgrade
|
| Current Ratio | 5.38 | 5.38 | 5.04 | 6.26 | 3.23 | 3.77 | Upgrade
|
| Return on Equity (ROE) | -4.73% | -4.73% | -20.78% | 1.33% | 41.41% | 29.45% | Upgrade
|
| Return on Assets (ROA) | -1.94% | -1.94% | -9.79% | -0.06% | 27.61% | 18.44% | Upgrade
|
| Return on Invested Capital (ROIC) | -4.86% | -4.64% | -22.34% | -0.14% | 63.97% | 45.84% | Upgrade
|
| Return on Capital Employed (ROCE) | -3.60% | -3.60% | -19.40% | -0.10% | 45.10% | 29.40% | Upgrade
|
| Earnings Yield | -3.40% | -3.88% | -17.36% | 2.34% | 23.45% | 9.92% | Upgrade
|
| FCF Yield | 6.48% | 7.38% | -1.84% | -1.10% | 7.81% | -0.11% | Upgrade
|
| Dividend Yield | - | - | - | 0.70% | 2.15% | 1.24% | Upgrade
|
| Payout Ratio | - | - | - | 114.22% | 6.62% | 8.93% | Upgrade
|
| Buyback Yield / Dilution | 2.88% | 2.88% | - | - | 0.02% | -7.39% | Upgrade
|
| Total Shareholder Return | 2.88% | 2.88% | - | 0.70% | 2.17% | -6.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.